Novo CEO pressed by Senate to chop price ranges of obesity, diabetes drugs CEO Lars Fruergaard Jørgensen explained to lawmakers the organization would take into consideration new talks with insurers in regards to the checklist price ranges of Wegovy and copyright when they pledge to maintain the medicines on their https://kethek.com/